The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Hepatocellular Adenoma and Focal Nodular Hyperplasia: Value of Gadoxetic Acid–enhanced MR Imaging in Differential Diagnosis
Abstract
PURPOSE: To retrospectively evaluate the utility of gadoxetic acid-enhanced magnetic resonance (MR) imaging in the differential diagnosis of hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH). MATERIALS AND METHODS: This study had institutional review board approval; the requirement for informed consent was waived. Eighty-two patients (58 patients with FNH and 24 patients with HCAs) with 111 lesions were included in the study. There were 74 female patients and eight male patients (mean age, 41.9 years±13.2 [standard deviation]; age range, 11-78 years). Two readers reviewed all images in terms of signal intensity (SI) features on unenhanced, dynamic, and hepatobiliary phase images. For quantitative analysis, contrast enhancement ratio (CER), lesion-to-liver contrast (LLC), and SI ratio on dynamic and hepatobiliary phase images were calculated. RESULTS: The CER of FNH in the arterial phase (mean, 94.3%±33.2) was significantly higher than that of HCAs (mean, 59.3%±28.1) (P<.0001). During the hepatobiliary phase, the LLC of FNH showed minimally positive values (mean, 0.05±0.01) and that of HCAs demonstrated strong negative values (mean, -0.67±0.24) (P<.0001). The area under the receiver operating characteristic curve of the hepatobiliary phase SI ratio for differentiation of the two tumors was 0.97, and a sensitivity of 92% and specificity of 91% were found with a cutoff value of 0.87. Among six FNH lesions that showed atypical hypointensity during the hepatobiliary phase, four had a large central scar, one contained a substantial fat component, and one had abundant radiating fibrous septa. Three HCAs were isointense during the hepatobiliary phase owing to severe hepatic steatosis. CONCLUSION: Gadoxetic acid-enhanced MR imaging facilitates the differentiation of FNH from HCA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Available, N. (2000) · JAMA · doi:10.1001/jama.284.23.3043 · Cited by 2,344
On the Pathogenesis of Focal Nodular Hyperplasia of the Liver
Wanless, I. R., Mawdsley, C., & Adams, R. (1985) · Hepatology · doi:10.1002/hep.1840050622 · Cited by 625
Epidemiology of hepatocellular adenoma. The role of oral contraceptive use
Rooks, J. B. (1979) · JAMA · doi:10.1001/jama.242.7.644 · Cited by 588
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl, T. J., Kümmel, S., Hammerstingl, R., Schellenbeck, M., Schumacher, G., Balzer, T., Schwarz, W., Müller, P. K., Bechstein, W. O., Mack, M. G., et al. (1996) · Radiology · doi:10.1148/radiology.200.1.8657946 · Cited by 453
Huppertz, A., Balzer, T., Blakeborough, A., Breuer, J., Giovagnoni, A., Heinz-Peer, G., Laniado, M., Manfredi, R. M., Mathieu, D. G., Mueller, D., et al. (2004) · Radiology · doi:10.1148/radiol.2301020269 · Cited by 396
Semelka, R. C., Martin, D. R., Balci, C., & Lance, T. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1057 · Cited by 274
Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma
Rebouissou, S., Bioulac-Sage, P., & Zucman-Rossi, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.10.003 · Cited by 252
Halavaara, J., Breuer, J., Ayuso, C., Balzer, T., Bellin, M.-F., Blomqvist, L., Carter, R., Grazioli, L., Hammerstingl, R., Huppertz, A., et al. (2006) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-200605000-00001 · Cited by 174
Self-citationMR Imaging of Hypervascular Liver Masses: A Review of Current Techniques
Silva, A. C., Evans, J. M., McCullough, A. E., Batheja, M. J., Vargas, H. E., & Hara, A. K. (2009) · Radiographics · doi:10.1148/rg.292085123 · Cited by 112
Diagnosis of Focal Nodular Hyperplasia: Not So Easy
Bioulac‐Sage, P., Balabaud, C. P., & Wanless, I. R. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200110000-00015 · Cited by 98
Cited by
EASL Clinical Practice Guidelines on the management of benign liver tumours
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.001 · Cited by 534
Hepatocellular Benign Tumors—From Molecular Classification to Personalized Clinical Care
Nault, J., Bioulac–Sage, P., & Zucman–Rossi, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.032 · Cited by 299
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
Thian, Y. L., Riddell, A. M., & Koh, D.-M. (2013) · Cancer Imaging · doi:10.1102/1470-7330.2013.0050 · Cited by 64
Metadata
- Authors
- Grazioli, L., Bondioni, M. P., Haradome, H., Motosugi, U., Tinti, R., Frittoli, B., Gambarini, S., Donato, F., & Colagrande, S.
- Venue
- Radiology
- Published
- 2012-02
- Volume
- 262
- Issue
- 2
- Pages
- 520-529
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2107770236
- Cited by
- 292
- References
- 14
- FWCI
- 26.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatocellular Adenoma and Focal Nodular Hyperplasia: Value of Gadoxetic Acid–enhanced MR Imaging in Differential Diagnosis. https://app.cochat.ai/papers/10.1148/radiol.11101742
- The paper
- Grazioli, L., Bondioni, M. P., Haradome, H., Motosugi, U., Tinti, R., Frittoli, B., Gambarini, S., Donato, F., & Colagrande, S. (2012). Hepatocellular Adenoma and Focal Nodular Hyperplasia: Value of Gadoxetic Acid–enhanced MR Imaging in Differential Diagnosis. Radiology. https://doi.org/10.1148/radiol.11101742
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.